Patents by Inventor Daniel Ignacio PÉREZ FERNÁNDEZ

Daniel Ignacio PÉREZ FERNÁNDEZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9796687
    Abstract: The present invention relates to a family of S-substituted quinazoline derivatives that inhibitors of the enzyme phosphodiesterase 7 (PDE7), useful for the treatment or prevention of diseases mediated by said enzyme, especially inflammatory, neurodegenerative, neurological, psychiatric and/or autoimmune diseases.
    Type: Grant
    Filed: May 17, 2016
    Date of Patent: October 24, 2017
    Assignee: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
    Inventors: Ana Martinez Gil, Carmen Belen Gil Ayuso-Gontan, Daniel Ignacio Perez Fernandez, Ana Maria Garcia Fernandez
  • Patent number: 9592224
    Abstract: The invention relates to a family of differently substituted benzothiazoles having inhibitory activity against casein kinase 1 (CK-1) enzyme, as a result of which they are suitable for use in the treatment or prevention of diseases caused by this enzyme, particularly diseases associated with circadian rhythm and inflammatory, autoimmune, psychiatric, neurodegenerative, neurological or ophthalmic diseases, as well as for inducing cell regeneration
    Type: Grant
    Filed: December 12, 2013
    Date of Patent: March 14, 2017
    Assignee: DONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC)
    Inventors: Ana Martínez Gil, Daniel Ignacio Pérez Fernández, Carmen Gil Ayuso-Gontán, Irene García Salado, Miriam Redondo Sancho, Concepción Pérez Martínez
  • Publication number: 20160340320
    Abstract: The present invention relates to a family of S-substituted quinazoline derivatives that inhibitors of the enzyme phosphodiesterase 7 (PDE7), useful for the treatment or prevention of diseases mediated by said enzyme, especially inflammatory, neurodegenerative, neurological, psychiatric and/or autoimmune diseases.
    Type: Application
    Filed: May 17, 2016
    Publication date: November 24, 2016
    Inventors: Ana Martinez Gil, Carmen Belen Gil Ayuso-Gontan, Daniel Ignacio Perez Fernandez, Ana Maria Garcia Fernandez
  • Publication number: 20150352082
    Abstract: The invention relates to a family of differently substituted benzothiazoles having inhibitory activity against casein kinase 1 (CK-1) enzyme, as a result of which they are suitable for use in the treatment or prevention of diseases caused by this enzyme, particularly diseases associated with circadian rhythm and inflammatory, autoimmune, psychiatric, neurodegenerative, neurological or ophthalmic diseases, as well as for inducing cell regeneration
    Type: Application
    Filed: December 12, 2013
    Publication date: December 10, 2015
    Applicant: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS
    Inventors: Ana MARTÍNEZ GIL, Daniel Ignacio PÉREZ FERNÁNDEZ, Carmen GIL AYUSO-GONTÁN, Irene GARCÍA SALADO, Miriam REDONDO SANCHO, Concepción PÉREZ MARTÍNEZ
  • Publication number: 20100041665
    Abstract: The present invention is related to a family of N-phenyl-prenylamine derivatives of formula (I), and to their use in the treatment of cognitive, neurodegenerative or neuronal diseases or disorders, such as Alzheimer's disease or Parkinson's Disease. The present invention also relates to pharmaceutical compositions comprising the same. Further, the present invention is directed to the use of the compounds in the manufacture of a medicament for the treatment and/or prevention of a cognitive, neurodegenerative or neuronal disease or disorder.
    Type: Application
    Filed: August 1, 2007
    Publication date: February 18, 2010
    Applicant: NOSCIRA, S.A.
    Inventors: Ana Martinez Gil, Ana Castro Morera, Miguel Medina Padilla, Pilar Munoz Ruiz, Javier Lopez Ogalla, Esther Garcia Palomero, Celia De Austria De Luque, Paola Usan Egea, Rita Valenzuela Liminana, Pablo Garcia Fernandez, Elena Delgado Hernandez, Daniel Ignacio Perez Fernandez
  • Publication number: 20090069430
    Abstract: The invention is directed to a compound of formula (I) Having VDCC blocking activity. These compounds are useful for the treatment of a series of human diseases and conditions, especially cognitive or neurodegenerative diseases or conditions.
    Type: Application
    Filed: June 16, 2008
    Publication date: March 12, 2009
    Applicant: NEUROPHARMA, S.A.
    Inventors: Ana MARTINEZ GIL, Ana Castro Morera, Miguel Medina Padilla, Pilar Munoz Ruiz, Laura Rubio Arrieta, Esther Garcia Palomero, Celia De Austria De Luque, Jorge Sanchez-Quesada, Daniel Ignacio Perez Fernandez, Javier Lopez Ogalla, Diana Alonso Gordillo
  • Patent number: 6747057
    Abstract: Compounds of formula I: [wherein: X represents —CH═CH—, —CH═CR—, —CR═CR—, —CO—, —O—, —NH—, —NR—, S—, —SO—, —SO2—, —CH═N—, —CR═N—, —CH═N(O)—, —CR═N(O)— or any other atom or group of atoms capable of forming a S— or 6-membered heterocyclic ring; Y1, Y2 and Y3 independently represent hydrogen or halogen; R1, R2 and R3 are independently represent hydrogen, halogen, hydrocarbyl (—R), hydroxyl (—OH), hydrocarbyloxy (—O—R), mercapto (—SH), hydrocarbylthio (—S—R), hydrocarbylsulfinyl (—SO—R), hydrocarbylsulfonyl (—SO2—R), nitro (—NO2), amino (—NH2), hydrocarbylamino (—NHR), bis(hydrocarbyl)amino (—NR2), hydrocarbylcarbonylamino (—NH—CO—R), cyano (—CN), carbamoyl (—CONH2), hy
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: June 8, 2004
    Assignees: Consejo Superior de Investigaciones Cientificas, Universidad Autonoma de Matrid (UAM)
    Inventors: Santiago Conde Ruzafa, Ana Martinez Gil, Daniel Ignacio Perez Fernandez, Maria Concepcion Perez Martin, Francisco Jose Moreno Munoz, Francisco Wandosell Jurado
  • Publication number: 20030199508
    Abstract: Compounds of formula I: 1
    Type: Application
    Filed: December 20, 2002
    Publication date: October 23, 2003
    Inventors: Santiago Conde Ruzafa, Ana Martinez Gil, Daniel Ignacio Perez Fernandez, Maria Concepcion Perez Martin, Francisco Jose Moreno Munoz, Francisco Wandosell Jurado